Nicotinic Acid Test

Your cells run on a molecule called NAD. It drives energy production, repairs damaged DNA, and regulates the enzymes that influence how quickly you age. Nicotinic acid (one of the forms of vitamin B3) is a primary precursor your body uses to make NAD. When nicotinic acid is low, NAD production slows, and the downstream effects can ripple across nearly every organ system.

For decades, nicotinic acid was best known as a lipid drug prescribed at high doses to raise HDL cholesterol. That era is largely over. Large trials showed the cardiovascular benefits never materialized, and major guidelines now recommend against pharmacologic niacin for heart disease prevention. But the nutrient itself, at dietary levels, tells a different story. Population data consistently links adequate niacin intake to lower mortality, and emerging research on NAD biology has renewed interest in understanding your niacin status from a longevity perspective.

What Nicotinic Acid Does in Your Body

Nicotinic acid (vitamin B3, also called niacin) is a small molecule with a simple structure: a six-membered ring containing nitrogen and a carboxylic acid group. Your body cannot make it from scratch. You get it from food or from a limited conversion pathway that turns the amino acid tryptophan into niacin (roughly 60 mg of tryptophan yields just 1 mg of niacin equivalent, making this route inefficient).

Once absorbed, nicotinic acid enters a biosynthesis pathway called the Preiss-Handler pathway, where an enzyme called NAPRT converts it into NAD. This coenzyme participates in glycolysis, the citric acid cycle, oxidative phosphorylation, and fatty acid metabolism. Beyond energy, NAD is consumed by enzymes that repair DNA (PARPs), regulate gene expression related to aging (sirtuins), and control calcium signaling (CD38). The small intestine, liver, and kidneys are especially active in converting nicotinic acid to NAD.

Your gut microbiome also plays a surprising role. Bacteria in the colon convert a related compound, nicotinamide, back into nicotinic acid, which the colon then absorbs. This recycling loop helps maintain circulating levels even when dietary intake dips temporarily.

Severe Deficiency: Pellagra

When nicotinic acid drops low enough that NAD production fails, the result is pellagra, a disease defined by the triad of dermatitis (a characteristic sunburn-like rash on sun-exposed skin), diarrhea, and dementia. Left untreated, pellagra is fatal. While rare in developed countries with fortified food supplies, pellagra still occurs in people with alcoholism (35% of contemporary cases in one literature review), those taking medications that interfere with niacin metabolism such as the tuberculosis drug isoniazid (25% of cases), and individuals with malabsorption syndromes (13% of cases).

A genetic condition called Hartnup disease, caused by a mutation in the tryptophan transporter SLC6A19, also increases pellagra risk by blocking one of the body's backup routes to make niacin.

Congenital Malformations and NAD Deficiency

Research published in the New England Journal of Medicine revealed that genetic defects in the enzymes that build NAD from scratch (specifically HAAO and KYNU) can cause a constellation of birth defects affecting the vertebrae, heart, kidneys, and limbs. In animal models, supplementing the mother's diet with niacin during pregnancy prevented these malformations entirely. This finding has significant implications for pregnancy planning, particularly for women with conditions that reduce NAD synthesis, such as type 2 diabetes, obesity, or chronic inflammation.

Dietary Niacin and Mortality

Several large analyses of the U.S. National Health and Nutrition Examination Survey (NHANES) database have examined dietary niacin intake and long-term survival. The pattern is consistent: people who eat more niacin-rich foods tend to live longer, with the association persisting after adjusting for age, sex, income, physical activity, and other dietary factors.

Sources: Lin et al. (2024, general population NHANES); Fu et al. (2024, metabolic syndrome NHANES); Yang R et al. (2024, CVD patients NHANES).

What this means for you: these are observational findings, and people who eat more niacin-rich foods likely have healthier diets overall. Still, the consistency across different populations, including those already diagnosed with heart disease or metabolic syndrome, suggests that adequate niacin intake matters beyond just preventing pellagra. An analysis of hypertensive individuals found a U-shaped relationship, where moderate niacin intake conferred the most benefit and very high intake offered diminishing returns.

Vascular Function

A study of 127 adults aged 48 to 77 found that those with above-average dietary niacin intake (at least 22 mg per day) had better blood vessel function and lower markers of oxidative stress compared to those consuming less. While this study was small, it points toward a mechanism that could explain the mortality associations: adequate niacin may help keep blood vessel linings healthy, independent of cholesterol effects.

The Pharmacologic Niacin Paradox

At doses of 1 to 6 grams per day, nicotinic acid powerfully reshapes your lipid profile: LDL cholesterol drops 10 to 20%, triglycerides fall 30 to 70%, and HDL cholesterol rises 20 to 35%. For years, this made niacin one of the most prescribed lipid drugs. But when researchers ran large randomized trials to see whether these lipid changes translated into fewer heart attacks and strokes, the answer was no.

A Cochrane meta-analysis pooling 23 trials and 39,195 participants found no reduction in overall mortality, cardiovascular mortality, heart attacks, or strokes with niacin therapy. A second meta-analysis of 17 studies with 35,760 participants confirmed these null results. When niacin was added on top of statin therapy, there was still no benefit. The FDA withdrew its approval for niacin-statin combination therapy in 2016, and both U.S. and European guidelines now recommend against using niacin for cardiovascular prevention.

Why did favorable lipid changes fail to save lives? One emerging explanation involves niacin's own breakdown products. A 2024 study in Nature Medicine found that terminal metabolites of niacin, specifically 2PY and 4PY, are associated with higher rates of cardiovascular events. These metabolites appear to promote vascular inflammation by stimulating a molecule called VCAM-1 on blood vessel walls. In other words, the process of metabolizing large doses of niacin may generate harmful byproducts that offset any benefit from improved cholesterol numbers.

Side Effects of High-Dose Niacin

Pharmacologic niacin carries a distinct side-effect profile. The most well-known is flushing: a warm, red, sometimes itchy sensation in the face and upper body that occurs because nicotinic acid activates a receptor called GPR109A on immune cells and skin cells, triggering prostaglandin release. Nicotinic acid also directly activates the capsaicin receptor (TRPV1, the same receptor that makes chili peppers burn), lowering its temperature threshold so it opens at normal body temperature. About 10% of people find the flushing intolerable enough to stop treatment.

More serious concerns include liver toxicity (especially with sustained-release formulations), worsened blood sugar control and increased diabetes risk, elevated uric acid and gout flares, gastrointestinal bleeding, and muscle damage when combined with statins. These risks apply to pharmacologic doses, not to dietary intake or standard multivitamin amounts.

Nicotinic Acid vs. Nicotinamide: A Common Source of Confusion

Both nicotinic acid and nicotinamide (also called niacinamide) are forms of vitamin B3, and both can be converted to NAD. But they are not interchangeable. Only nicotinic acid activates the GPR109A receptor, causes flushing, and has lipid-modifying effects. Nicotinamide does none of these things. If you see "niacin" on a supplement label, check which form it contains. Many over-the-counter products use nicotinamide, which will fulfill your vitamin needs but will not affect your cholesterol.

Assessing Your Niacin Status

Direct measurement of nicotinic acid in blood is tricky because the molecule clears rapidly, with a half-life of just 20 to 45 minutes. A blood level reflects what you consumed in the past hour more than your long-term niacin stores. For this reason, clinical assessment of niacin status traditionally relies on urinary metabolites (specifically N1-methylnicotinamide and a related compound called 2-pyridone), which together achieved 91% sensitivity and 72% specificity for detecting pellagra in one validation study.

Whole blood NAD and NADP concentrations were studied as potential alternatives, but they failed to detect clinical pellagra in one trial, making them unreliable on their own. The erythrocyte (red blood cell) NAD level and the ratio of NAD to NADP in red blood cells may offer earlier detection of marginal deficiency, but these are research tools, not widely available commercial tests.

Reference Ranges for Dietary Intake

Because circulating nicotinic acid levels are not standardized as a clinical biomarker, the most useful reference framework is based on daily intake rather than blood concentration.

These tiers are drawn from published dietary reference intakes and observational research. Your lab may report a blood level in nmol/mL, but standardized clinical cutpoints for blood nicotinic acid do not yet exist. Compare your results within the same lab over time for the most meaningful trend.

Tracking Your Trend

A single nicotinic acid measurement is a snapshot of the past hour, not your long-term niacin status. The molecule's short half-life (20 to 45 minutes) means that timing relative to meals, supplements, and even hot beverages can dramatically shift your reading. This makes serial tracking more valuable than any individual result.

If you are testing to assess nutritional adequacy, get a baseline under consistent conditions (same time of day, same fasting status, same distance from any supplement dose). If you make dietary changes aimed at increasing niacin intake, retest in 4 to 8 weeks under identical conditions. Annual monitoring is reasonable for ongoing tracking, with more frequent testing if you have a condition that impairs niacin absorption or metabolism.

Tracking your trend lets you see whether a dietary shift is actually reaching your bloodstream, catch a downward drift before symptoms appear, and verify that supplementation (if you use it) is staying within a range that supports NAD production without generating excess metabolites.

Why a Single Reading Can Fool You

The most important confounder is timing. Because nicotinic acid peaks within 30 to 60 minutes of ingestion and clears within an hour or two, a blood draw taken shortly after a niacin-rich meal or supplement will look very different from one taken in a fasted state. Always standardize your pre-test routine.

Sex also matters: women tend to have higher steady-state plasma concentrations of nicotinic acid and its metabolites than men at the same dose, likely due to differences in metabolic rate or body composition. Kidney function affects clearance, since about 88% of a pharmacologic dose is eliminated through the kidneys. If your kidney function is reduced, nicotinic acid may accumulate, producing a falsely reassuring high reading that does not reflect dietary adequacy. Aspirin can slow niacin metabolism, and bile acid sequestrants (like cholestyramine) can bind and reduce niacin absorption by up to 98% if taken at the same time.